INM

Dopo l'orario di chiusura: 1.32 0.01 +0.76%

Inmed Pharmaceuticals Inc (INM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Inmed Pharmaceuticals Inc

Healthcare (1069)

(604) 669-7207

1445-885 WEST GEORGIA ST., VANCOUVER

Prossima data di guadagno

Ultimi documenti SEC

INM's Discussions on Twitter

Compare INM vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INM Inmed Pharmaceuticals Inc	1.31	6.99M	3.25M	-8.34M	-7.71M	-2.5755
TAK Takeda Pharmaceutical Co Adr	18.11	58.15B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.35	42.94B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.22	40.59B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.86	30.29B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	503.86	21.74B	3.17B	1.29B	1.01B	27.09

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Compare INM vs TAK, TEVA, HLN, ZTS, UTHR

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

InMed winds down only revenue-generating business BayMedica - Minichart

GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

[S-4/A] InMed Pharmaceuticals Inc. Amended Business Combination Registration | INM SEC FilingForm S-4/A - Stock Titan

InMed Pharmaceuticals Inc. FY 2026: Revenue $3.18M, EPS ($3.12) — 10-K Summary - TradingView

InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update - Yahoo Finance

InMed (INM) Earnings Update: The Company Publishes Its Latest Results in the Latest Session; Price Reaction: Shares Close 7.59% Lower for the Current SessionSegment Revenue Breakdown - vinanet.vn

InMed (INM) Price: Finishes 7.59% Down at $1.46 in the Latest Session; Technical Setup: Price Remains Between $1.39 Support and $1.53 Resistance under the Current SnapshotIntraday Profile - vinanet.vn

InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateEarnings Growth Forecast - vinanet.vn

InMed (INM) Session: Adds 0.63% to Close at $1.60 in Latest Trading; Current Setup: Traders Can Monitor the $1.52-$1.68 RangeVolatility Skew - vinanet.vn

InMed Pharmaceuticals (INM) Holds Above Support After 2.8% GainCash Secured Put - vinanet.vn

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share; Stock Rises 2.8%One-Time Gain Impact - vinanet.vn

InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares - Stock Titan

Inmed Pharmaceuticals Stock Price Forecast. Should You Buy INM? - StockInvest.us

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Biopharmaceutical InvestmentRevenue Breakdown Analysis - vinanet.vn

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share ReportedFinancial Data - Vinanet

InMed Pharmaceuticals (INM) Rises 3.55% to $1.46 as Buyers Defend Key SupportMA Crossover - dars.gov.et

InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

InMed Pharmaceuticals (INM) Slips 6% to $1.40 as Support Level Comes into FocusDefined Outcome ETF - vinanet.vn

InMed Pharmaceuticals (INM) Rises 2.40% as Shares Approach Key $1.58 ResistanceSector Leader Stocks - vinanet.vn

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Clinical InvestmentNet Profit Margin - vinanet.vn

INM Q3 2025 Earnings: Narrowing Losses and Cautious Pipeline ProgressRevenue Growth Report - vinanet.vn

InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey

INM|InMed Pharmaceuticals Inc|Price:1.580|Chg%:-0.130 - TradingKey

TradingKey - TradingKey

INM|InMed Pharmaceuticals Inc|Price:1.670|Chg%:-0.040 - TradingKey

InMed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:INM - TradingView

InMed Pharmaceuticals Inc (INM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

ADAR1 Capital Management, LLC Acquires Additional Shares in InMed Pharmaceuticals Inc - GuruFocus

INM Q3 2025 Earnings: InMed Pharmaceuticals Reports Net Loss of $1.94 Per Share as Stock Rises 11.45%Guidance Accuracy Score - dars.gov.et

Mentari Therapeutics Raises $200 Million for Migraine Prevention Pipeline Ahead of InMed Merger - Minichart

InMed Pharmaceuticals (INM) plans Mentari merger with $490M financings - Stock Titan

InMed to Merge with Mentari as Mentari Secures $200M Pre-Closing Financing - TradingView

InMed Pharmaceuticals Merger Partner Raises $200 Million To Boost Migraine Pipeline - Benzinga

INM Stock Whipsaws As InMed Refines Mentari Merger Terms - StocksToTrade

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations - TechStock²

INM Stock Jumps As Traders Digest Amended Mentari Merger - StocksToTrade

INM Stock Jumps As Amended Mentari Merger Takes Shape - timothysykes.com

Morning Market Movers: INM, INLF, SXTC, ADVB See Big Swings - RTTNews

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PR Newswire

InMed Pharmaceuticals Inc (NASDAQ: INM) Share Price, INM Stock News, INM Share Price & Updates - Kalkine

InMed (NASDAQ: INM) outlines Mentari merger structure and names new CEO - Stock Titan

InMed Pharmaceuticals (INM) Gains 1.3% as Stock Approaches Key Resistance LevelForce Index - dars.gov.et

ADAR1 Capital acquires 1,000 InMed common shares worth $1,555 - Bitget

InMed Pharmaceuticals (INM) holder buys 1,000 common shares via ADAR1 - Stock Titan

Vivo Opportunity reports USD 32,319 purchase of InMed common shares - Bitget

Vivo Opportunity funds add 20,546 InMed Pharmaceuticals (INM) shares - Stock Titan

Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a INM